● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

HIKAL

BSE
Hikal Limited
Healthcare· Pharmaceuticals & Biotechnology· INE475B01022· Scrip: 524735
ENहिन्दीગુજરાતીमराठी
178.00
3.40 (+0.00%)
2026-06-10
BSE
178.00
3.40
+0.00%
15520826231536906-1808-1110-0712-0201-2803-2505-2706-10
231 trading days · 1Y period
TODAY (BSE)
Open180.60
High183.90
Low177.80
Prev Close181.40
Volume9,327
Value₹0.2Cr
L: 177.80H: 183.90
Info
Face Value₹2
Listed2001-02-14
ISININE475B01022
SeriesB
BSE Scrip524735

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-1.15%
PAT-6.01%
EPS-6.08%
Profitability
Dividend
Growth-75.00%
TTM Revenue
₹1822 Cr
TTM EBITDA
₹311 Cr
TTM PAT
₹75 Cr
TTM EPS
₹6.05
Rev/Share
₹147.7

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr136 Cr273 Cr409 Cr545 Cr22-1223-0323-0923-1224-0324-0624-0924-122.12.91.01.32.80.41.51.4
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31448 Cr428 Cr82 Cr24 Cr17 Cr1.39
2024-09-30453 Cr429 Cr82 Cr25 Cr18 Cr1.48
2024-06-30407 Cr400 Cr39 Cr7 Cr5 Cr0.42
2024-03-31514 Cr467 Cr108 Cr47 Cr34 Cr2.76
2023-12-31448 Cr426 Cr70 Cr22 Cr16 Cr1.31
2023-09-30435 Cr419 Cr63 Cr17 Cr13 Cr1.02
2023-03-31545 Cr497 Cr101 Cr49 Cr36 Cr2.92
2022-12-31540 Cr507 Cr86 Cr36 Cr26 Cr2.14

Shareholding Pattern

CURRENT2026-03-31
68.8%PROMOTER
Promoter68.8%
FII1.4%
DII7.2%
Public31.1%
PROMOTER HOLDING TREND
68.8%24-0668.8%24-0968.8%24-1268.8%25-0368.8%25-0968.8%25-1268.8%26-03

Corporate Actions

Ex-DateTypePurpose
2026-02-17DividendInterim Dividend - Re 0.20 Per Share
2025-09-02DividendDividend - Rs 0.80 Per Share
2025-02-07DividendInterim Dividend - Re 0.60 Per Share
2024-09-10OtherAnnual General Meeting
2024-09-04DividendDividend - Re 0.60 Per Share
2024-02-20DividendInterim Dividend - Rs 0.60 Per Sh
2023-09-18DividendAnnual General Meeting/Dividend - Rs 0.60 Per Share
2023-02-14DividendInterim Dividend - Re 0.60 Per Share
2022-09-14DividendDividend - Re 0.40 Per Share
2022-09-14OtherAnnual General Meeting
2022-02-23DividendInterim Dividend - Rs 1.20 Per Share
2021-08-25Dividend Dividend - Re 1 Per Share
2021-02-15Dividend Interim Dividend - Re 1 Per Share
2020-09-07Dividend Annual General Meeting/Dividend - Rs 0.20 Per Share
2020-02-17Dividend Interim Dividend - Re 1 Per Share
2019-07-23Dividend Annual General Meeting/Dividend - Re 0.60 Per Share
2019-02-13Dividend Interim Dividend - Re 0.60 Per Share
2018-07-31Dividend Annual General Meeting/Dividend- Re 0.50 Per Share
2018-06-22Bonus Bonus 1:2
2018-02-21Dividend Interim Dividend Re 0.70 Per Share

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10181.32184.39177.93178.311.60L
2026-06-03191.42192.99186.94187.981.12L
2026-05-27218.59228.00218.00221.3210.09L
2026-05-26214.01220.37212.30218.055.59L
2026-05-25207.10215.00206.39214.064.45L
2026-05-22206.00209.80204.88205.341.16L
2026-05-21205.98209.36203.65205.501.90L
2026-05-20202.40208.35200.20204.692.01L
2026-05-19196.87206.00196.81203.782.04L
2026-05-18201.39201.39194.01196.441.68L
2026-05-15209.70209.80201.00201.461.64L
2026-05-14202.05210.00198.73208.763.27L
2026-05-13198.68204.90198.21201.821.82L
2026-05-12208.10209.96197.12198.682.66L
2026-05-11209.40214.60207.50209.403.03L
2026-05-08212.95218.00210.09210.753.44L
2026-05-07210.72217.00207.40212.904.79L
2026-05-06199.20212.77197.50211.3413.86L
2026-05-05196.50199.00193.00197.053.28L
2026-05-04189.85197.00189.52194.722.34L
2026-04-30188.55190.98185.25189.251.93L
2026-04-29188.01194.40186.11189.143.47L
2026-04-28190.63190.63187.00187.721.42L
2026-04-27182.51190.25182.01189.152.01L
2026-04-24188.37188.37179.50181.102.61L
2026-04-23188.38191.50186.25187.132.26L
2026-04-22188.39189.63186.51189.211.57L
2026-04-21188.81192.00187.00187.611.67L
2026-04-20194.79194.79187.12188.394.38L
2026-04-17189.86193.88188.65191.903.11L

Frequently Asked Questions

About

Hikal Limited, listed on the National Stock Exchange (NSE) under the code HIKAL, is an Indian pharmaceutical company primarily focused on research and development with its headquarters in Pune, Maharashtra. The company specializes in developing and manufacturing a range of pharmaceutical products, including anti-infectives, cardiovascular drugs, and generic formulations. Notably, Hikal was founded in 1968 and has established itself as a significant player in the Indian pharmaceutical sector, contributing to both domestic and international markets.

BOARD OF DIRECTORS
Sarangan Suresh
Executive Director
Kannan Unni
Independent Director
DEPARTED
Ranjit Gobindram Shahani
Independent Director
DEPARTED
Shivani Bhasin Sachdeva
Independent Director
Wolfgang Welter
Independent Director
Ravi Brijmohan Kapoor
Additional Director